Lee Ainslie’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Lee Ainslie's REGN Position: Q3 2026 in Review
Lee Ainslie opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2026: 1,824 shares worth $1.38M. The stake represents 0.01% of the portfolio and ranks #145 among its holdings. This is a return to the name: Lee Ainslie previously reported a position in REGN as recently as Q4 2023.
Lee Ainslie first reported a position in REGN in Q3 2020 and has held it in 4 quarters since. The position peaked at $1.54M in Q4 2023. 1,423 funds tracked by Wall St. Rank hold REGN as of Q3 2026.
- Lee Ainslie held 1,824 shares of Regeneron Pharmaceuticals worth $1.38M as of Q3 2026.
- Regeneron Pharmaceuticals was a new Lee Ainslie position in Q3 2026.
- Regeneron Pharmaceuticals made up 0.01% of Lee Ainslie's portfolio in Q3 2026, its #145 holding.
- Lee Ainslie first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 4 quarters since.
- Lee Ainslie's Regeneron Pharmaceuticals position peaked at $1.54M in Q4 2023.
- 1,423 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2026.
Based on Maverick Capital's 13F filing for Q3 2026, filed 16 Nov 2026.